CRISPR’d Cells Show Promise in First U.S. Human Safety Trial

Last year, three cancer patients were treated with their own CRISPR-edited T cells as part of a groundbreaking U.S. trial to determine the safety of such a treatment.

The result? A promising breakthrough for gene editing.

Article from Wired